ArticleAlimentary pharmacology & therapeutics2025

Coronary Artery Disease and Major Adverse Cardiovascular Events in People With Hepatic Steatosis at Low Atherosclerotic Cardiovascular Disease Risk.

Julia Karady et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.